Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

NCT06969170 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Generalized Anxiety Disorder (GAD)

Interventions

DRUG: Psilocybin (drug)
OTHER: Placebo

Sponsor

Queen's University

Collaborators

[object Object]
[object Object]